Congruently, we find that the specific silencing of Nupr1 in pancreatic cancer cells increases the levels of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1(Figures 3a, c and d). Here, CDKN1B is linked to pancreatic neoplasm.